NS-PRIME Trademark

Trademark Overview


On Wednesday, February 26, 2020, a trademark application was filed for NS-PRIME with the United States Patent and Trademark Office. The USPTO has given the NS-PRIME trademark a serial number of 79281547. The federal status of this trademark filing is REGISTERED as of Tuesday, March 30, 2021. This trademark is owned by Alfresa Pharma Corporation. The NS-PRIME trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Medical in vitro diagnostic reagents for analyzing fecal human hemoglobin; medical in vitro diagnostic reagents for analyzing fecal transferrin; diagnostic preparations for medical purposes; diagnostic reagents for medical use; medical diagnostic fecal immunochemical test reagents for human hemoglobin; medical diagnostic fecal occult blood test reagents for human hemoglobin; medical diagnostic fecal immunochemical test reagents for human transferrin; medical diagnostic fecal occult blood test reagents for human transferrin

Automated immunological fecal occult blood analyzers for medical diagnostic uses; automated fecal occult blood analyzers for medical diagnostic uses; chemical clinical analyzing apparatus in the nature of apparatus for analyzing bodily fluids for medical purposes; automated discrete clinical chemistry analyzers for analyzing bodily fluids for medical diagnostic uses; clinical medical diagnostic instruments for the analysis of body fluids; fecal immunochemical test analyzers for medical diagnostic uses
ns-prime

General Information


Serial Number79281547
Word MarkNS-PRIME
Filing DateWednesday, February 26, 2020
Status700 - REGISTERED
Status DateTuesday, March 30, 2021
Registration Number6303273
Registration DateTuesday, March 30, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 12, 2021

Trademark Statements


Goods and ServicesMedical in vitro diagnostic reagents for analyzing fecal human hemoglobin; medical in vitro diagnostic reagents for analyzing fecal transferrin; diagnostic preparations for medical purposes; diagnostic reagents for medical use; medical diagnostic fecal immunochemical test reagents for human hemoglobin; medical diagnostic fecal occult blood test reagents for human hemoglobin; medical diagnostic fecal immunochemical test reagents for human transferrin; medical diagnostic fecal occult blood test reagents for human transferrin
Goods and ServicesAutomated immunological fecal occult blood analyzers for medical diagnostic uses; automated fecal occult blood analyzers for medical diagnostic uses; chemical clinical analyzing apparatus in the nature of apparatus for analyzing bodily fluids for medical purposes; automated discrete clinical chemistry analyzers for analyzing bodily fluids for medical diagnostic uses; clinical medical diagnostic instruments for the analysis of body fluids; fecal immunochemical test analyzers for medical diagnostic uses

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 23, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, March 23, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAlfresa Pharma Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameAlfresa Pharma Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameAlfresa Pharma Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Friday, May 12, 2023INTERNATIONAL REGISTRATION RENEWED
Saturday, July 31, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, July 8, 2021FINAL DISPOSITION NOTICE SENT TO IB
Thursday, July 8, 2021FINAL DISPOSITION PROCESSED
Wednesday, June 30, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 30, 2021REGISTERED-PRINCIPAL REGISTER
Friday, January 15, 2021NOTIFICATION PROCESSED BY IB
Tuesday, January 12, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 12, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 23, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 23, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 23, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 9, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 8, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, December 8, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, December 8, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, December 8, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, July 20, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 20, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 20, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, July 20, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 20, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 20, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 17, 2020REFUSAL PROCESSED BY IB
Wednesday, June 24, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, June 24, 2020REFUSAL PROCESSED BY MPU
Thursday, May 21, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, May 20, 2020NON-FINAL ACTION WRITTEN
Thursday, May 14, 2020ASSIGNED TO EXAMINER
Friday, March 27, 2020APPLICATION FILING RECEIPT MAILED
Monday, March 23, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 19, 2020SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB